| Primary |
| Hypertension |
20.7% |
| Bone Disorder |
10.3% |
| Constipation |
10.3% |
| Hypertensive Crisis |
10.3% |
| Hereditary Disorder |
6.9% |
| Hormone Replacement Therapy |
6.9% |
| Rheumatoid Arthritis |
6.9% |
| Anxiety |
3.4% |
| Atrophic Vulvovaginitis |
3.4% |
| Autoimmune Thyroiditis |
3.4% |
| Depression |
3.4% |
| Familial Risk Factor |
3.4% |
| Osteopenia |
3.4% |
| Post-traumatic Stress Disorder |
3.4% |
| Vaginal Discharge |
3.4% |
|
| Heart Rate Irregular |
20.0% |
| Pancreatitis |
20.0% |
| Spinal Operation |
20.0% |
| Sudden Death |
20.0% |
| Vaginal Discharge |
20.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
48.1% |
| Supplementation Therapy |
7.6% |
| Heart Transplant |
6.1% |
| Drug Exposure During Pregnancy |
5.3% |
| Arthritis |
3.1% |
| Dermatitis |
3.1% |
| Nephrotic Syndrome |
3.1% |
| Osteoporosis |
3.1% |
| Liver Transplant |
2.3% |
| Routine Health Maintenance |
2.3% |
| Vitamin Supplementation |
2.3% |
| Arthropathy |
1.5% |
| Blood Cholesterol Increased |
1.5% |
| Glomerulonephritis |
1.5% |
| Medical Diet |
1.5% |
| Mineral Supplementation |
1.5% |
| Muscle Spasms |
1.5% |
| Mycotic Allergy |
1.5% |
| Osteopenia |
1.5% |
| Peritoneal Dialysis |
1.5% |
|
| Vomiting |
16.2% |
| Dysmorphism |
10.8% |
| Toothache |
8.1% |
| Nausea |
5.4% |
| Renal Failure |
5.4% |
| Sarcoidosis |
5.4% |
| Tachycardia |
5.4% |
| Tooth Injury |
5.4% |
| Upper Limb Fracture |
5.4% |
| Weight Decreased |
5.4% |
| Blindness Transient |
2.7% |
| Dyspepsia |
2.7% |
| Hepatic Enzyme Increased |
2.7% |
| Multiple Allergies |
2.7% |
| Nephrolithiasis |
2.7% |
| Oral Torus |
2.7% |
| Renal Failure Acute |
2.7% |
| Renal Tubular Disorder |
2.7% |
| Thirst |
2.7% |
| Thyroid Disorder |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.8% |
| Drug Use For Unknown Indication |
22.2% |
| Osteoporosis |
7.7% |
| Rheumatoid Arthritis |
7.4% |
| Hypertension |
5.3% |
| Pain |
3.5% |
| Crohn's Disease |
3.3% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Vitamin Supplementation |
2.4% |
| Mineral Supplementation |
2.4% |
| Prophylaxis |
2.2% |
| Blood Cholesterol Increased |
2.0% |
| Depression |
1.9% |
| Breast Cancer |
1.6% |
| Anxiety |
1.4% |
| Diabetes Mellitus |
1.4% |
| Arthritis |
1.3% |
| Insomnia |
1.3% |
| Colitis Ulcerative |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
|
| Vomiting |
14.1% |
| Weight Decreased |
12.7% |
| Urinary Tract Infection |
6.4% |
| Pain |
5.9% |
| Weight Increased |
5.4% |
| Nausea |
5.0% |
| Injection Site Pain |
4.9% |
| Pyrexia |
4.7% |
| Pneumonia |
4.5% |
| Rash |
4.0% |
| Tremor |
3.9% |
| Pruritus |
3.7% |
| Vision Blurred |
3.5% |
| Myocardial Infarction |
3.2% |
| Pulmonary Embolism |
3.2% |
| Death |
3.0% |
| Drug Ineffective |
3.0% |
| Dyspnoea |
3.0% |
| Urticaria |
3.0% |
| White Blood Cell Count Decreased |
3.0% |
|
| Interacting |
| Blood Cholesterol Increased |
25.0% |
| Cerebrovascular Accident |
25.0% |
| Hypertension |
25.0% |
| Joint Swelling |
25.0% |
|
| International Normalised Ratio Decreased |
33.3% |
| Loss Of Consciousness |
33.3% |
| Memory Impairment |
33.3% |
|
